Novo CEO Sees Strong Demand for Wegovy Obesity Pill

Novo Nordisk CEO Mike Doustdar talks about launching a pill version of their blockbuster obesity drug Wegovy in the US. He speaks to Katie Greifeld in San Francisco at the annual JPMorgan Healthcare Conference. (Source: Bloomberg)...

Redirecting to full article...